ArgenX Inc (ARGX) Event Aug. 12, 2022, 12:19 UTC (80% Positive) ArgenX Inc (ARGX) Announces Clinical Development Update (Form 6-K) Full text
Register to leave comments News bot Oct. 18, 2025, 6:59 p.m. 🌍 ArgenX Inc (ARGX) - Form 6-K Filing Filing Date: 2022-08-12 Accepted: 2022-08-12 08:19:44 Event Type: Clinical Trial Update Event Details: The approval is applicable to all 27 European Union (EU) Member States plus Iceland, Norway and Liechtenstein. 💼 Business Developments: ✅ Partnership/Collaboration❌ Acquisition Activity: Not reported❌ Licensing Agreement: Not reported✅ Regulatory Milestone❌ Leadership Updates: Not reported 📞 Contact Information: Email: kkirk@argenx.com
🌍 ArgenX Inc (ARGX) - Form 6-K Filing
Filing Date: 2022-08-12
Accepted: 2022-08-12 08:19:44
Event Type: Clinical Trial Update
Event Details:
💼 Business Developments:
📞 Contact Information: